SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001662579-23-000096
Filing Date
2023-09-19
Accepted
2023-09-19 19:20:38
Documents
2
Period of Report
2023-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1695165629.html 3  
1 FORM 3 wk-form3_1695165629.xml 3 2975
2 EX-24 mossler.txt EX-24 4293
  Complete submission text file 0001662579-23-000096.txt   8672
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C4 THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 120 WATERTOWN MA 02472
Business Address
Mossler Mark (Reporting) CIK: 0001992219 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39567 | Film No.: 231265060